Synchronized electromechanical integration recording of cardiomyocytes

Area of Science:

• Cardiovascular Research
• Biomedical Engineering
• Pharmacology

Background:

• Cardiac arrhythmias pose significant health risks, necessitating improved preclinical assessment strategies.
• Existing methods for studying cardiac excitation-contraction coupling are limited by asynchronicity, label interference, or adverse effects.
• A precise, label-free, and synchronized approach is crucial for understanding cardiac dysfunction.

Purpose of the Study:

• To develop and validate a label-free, synchronized detection strategy for simultaneous monitoring of cardiac electrical and mechanical signals.
• To assess the utility of this strategy in evaluating drug-induced changes in excitation-contraction coupling and identifying specific drug targets.
• To explore the potential of a biomimetic electronic pacemaker for arrhythmia assessment.

Main Methods:

• Development of an integrated microelectrode-interdigitated electrode (ME-IDE) system for label-free, synchronized electromechanical integration detection.
• Long-term monitoring of cardiomyocyte electrical and mechanical signals using the ME-IDE.
• Utilizing electromechanical integration delay to specifically recognize sodium channel inhibition.
• Employing a biomimetic electronic pacemaker to assess drug-induced arrhythmia via cardiomyocyte refractory period.

Main Results:

• The ME-IDE system successfully achieved synchronous, long-term monitoring of electromechanical signals in cardiomyocytes.
• The strategy effectively detected subtle changes in electromechanical integration induced by drugs targeting excitation-contraction coupling.
• Electromechanical integration delay was identified as a specific indicator for sodium channel inhibition.
• The biomimetic electronic pacemaker demonstrated efficacy in assessing drug-induced arrhythmias.

Conclusions:

• The label-free synchronized electromechanical integration detection strategy offers a powerful tool for preclinical cardiac research.
• This method overcomes limitations of conventional techniques, enabling precise, quantitative assessment of cardiac excitation-contraction coupling.
• The developed technology facilitates accurate drug screening and mechanistic studies for cardiovascular diseases and arrhythmias.